Kalkine Media Market update
News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 1–36
- Matches
- 409
- Sources here
- 18
- Companies here
- 11
Active search
409 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Spire Inc. Stock 12‑Month Price Target Cut to $93.22, Implies 13% Upside
The average 12-month price target for Spire Inc. (SR) stock has been reduced to $93.22 from $94.2 by nine analysts, with forecasts ranging from $85 to $100 per share. This new target implies a potential 13% upside based on the Aug. 14 closing price. …
InspireMD, Inc. (NSPR) Reports Q2 Loss, Beats Revenue Estimates
InspireMD, Inc. (NSPR) reported a Q2 loss of $0.17 per share, outperforming the Zacks Consensus Estimate of a $0.2 loss and representing a 15% earnings surprise. The company's revenues for the quarter were $1.77 million, surpassing estimates by 7.33%, although slightly down from the …
BrightSpire Capital (BRSP) investor group discloses 8.6% stake in Class A shares
A shareholder group led by CWRE SSF Securities Holding, LP, CWRE Special Situations Fund GP, LLC, CW Investment Advisers, LLC, and Hon Kit Shing has disclosed an 8.6% beneficial ownership stake in BrightSpire Capital, Inc.'s Class A common stock. This ownership amounts to 10,812,258 …
INSPIREMD Q2 2026 Earnings Preview: Recent $NSPR Insider Trading, Hedge Fund Activity, and More
INSPIREMD (NSPR) is set to release its Q2 2026 earnings on August 17th, with analysts forecasting revenue of $1.41 million and a loss of $0.20 per share. Recent insider trading shows more purchases than sales, while hedge fund activity indicates both increased and decreased …
InspireMD (NSPR) grows revenue 56% but flags going concern and Nasdaq risk
InspireMD, Inc. reported increased revenues for the first half of 2026, up 56.3% to $5.17 million, driven by U.S. CGuard Prime sales and international growth, despite a voluntary recall of CGuard Prime impacting quarterly revenue and gross margin. The company posted a significant net …
Nut Tree Capital (BRSP) discloses 1.5% BrightSpire Capital stake in 13G/A
Nut Tree Capital, through its affiliated entities, has reported a beneficial ownership of 1.5% in BrightSpire Capital, Inc.'s Class A common stock, totaling 1,937,826 shares. This disclosure was made in a Schedule 13G/A filing with the SEC, indicating shared voting and dispositive power over …
Ispire Technology Inc. (ISPR) director receives 53,555-share compensation grant
Ispire Technology Inc. director Brent Cox received a compensation grant of 53,555 shares of common stock on August 14, 2026, as reported in a Form 4 SEC filing. The shares were granted for services rendered, with a reported price of $0.00 per share, increasing …
Responsive Playbooks and the SPIR Inflection
Spire Global Inc. (NASDAQ: SPIR) shows strong sentiment across all horizons, supporting an overweight bias. AI models have generated three distinct trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss zones. The analysis highlights an exceptional 116.5:1 risk-reward setup, targeting …
Spire Global Submits Q2 2026 Form 10-Q to SEC Detailing Share Counts and Filing Status
Spire Global, Inc. has submitted its Q2 2026 Form 10-Q report to the SEC, revealing 39,115,046 shares of Class A common stock and 1,507,325 shares of Class B common stock outstanding as of August 10, 2026. The company is classified as a non-accelerated filer …
Aspire Biopharma (NASDAQ: ASBP) slashes H1 2026 loss and rebuilds equity
Aspire Biopharma (NASDAQ: ASBP) reported significantly reduced net losses in the first half of 2026, dropping to $4.49 million from $17.92 million a year prior, largely due to lower stock-based compensation and financing costs. The company also substantially improved its balance sheet, moving from …
Inspire Medical Systems (INSP): Soleus Capital group reports 6.7% ownership stake
Soleus Capital Master Fund, L.P. and affiliated entities have reported a 6.7% ownership stake in Inspire Medical Systems, Inc. (INSP), holding 1,931,436 shares of common stock. This beneficial ownership is based on 28,910,375 shares outstanding as of July 30, 2026, and grants shared voting …
Spire reaffirms $75M-$85M 2026 revenue outlook as it negotiates an 8-figure NOAA microwave sounding award
Earnings Call Insights: Spire Global, Inc. (SPIR) Q2 2026 MANAGEMENT VIEW * "Revenue for the second quarter was $18 million." (CEO, President & Director Theresa Condor) "Excluding the maritime business we divested last year, core revenue expanded both year-over-year and sequentially, marking our strongest …
Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19th
Aspire Biopharma Holdings, Inc. announced its participation in Sidoti & Company's Micro-Cap Virtual Investor Conference on August 19-20, 2026. Management will host one-on-one meetings and discuss its clinical pipeline and recent acquisition of Dura Driver Control Systems. The presentation is scheduled for August 19, …
Spire Inc. (SR) VP awarded 1,230 restricted shares and phantom stock units
Timothy W. Krick, VP and Chief Accounting Officer at Spire Inc. (SR), was awarded 1,230 shares of time-vested restricted common stock valued at $81.04 per share, vesting on August 10, 2028. This award increases his direct holdings to 8,090 shares, in addition to indirect …